MIRA Pharmaceuticals (MIRA) Stock: Buy, Sell, or Hold?
MIRA - MIRA Pharmaceuticals, Inc. Common Stock
$0.77
-0.02 (-1.95%)
âŧ
5d:
+4.62%
30d:
+4.75%
90d:
-19.4%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When MIRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MIRA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MIRA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MIRA is currently trading at $0.77, which is considered fair relative to its 30-day fair value range of $0.72 to $0.80.
Technical Outlook: Technically, MIRA is in a strong downtrend. Immediate support is located at $0.72, while resistance sits at $1.10.
Market Sentiment: MIRA scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.75 (+2193.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MIRA is in a strong downtrend. Immediate support is located at $0.72, while resistance sits at $1.10.
Market Sentiment: MIRA scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.75 (+2193.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.72 -
$0.80
Company Quality Score
32/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
44.7%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (20/100)
- BULLISH: Trading 2193.9% below Wall St target ($17.75)
- WARNING: Composite score 32/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.72 -
$0.80
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.72
Resistance Level
$1.10
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.89
Wall Street Target
$17.75
(+2193.9%)
Share & Embed Analysis
Last updated: September 13, 2026 12:31 PM ET
Data refreshes hourly during market hours. Next update: 1:31 PM
Data refreshes hourly during market hours. Next update: 1:31 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MIRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1319 | 47 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 44 HOLD |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$277 | 53 HOLD |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$237 | 47 HOLD |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$388 | 43 HOLD |
